Detalhe da pesquisa
1.
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Hepatology
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447019
2.
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
Clin Gastroenterol Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782175
3.
Clinical profile of Spanish hepatitisC virus-infected treatment-naïve patients with compensated cirrhosis in the CREST study. / Perfil clínico de los pacientes españoles con hepatitisC naïve con cirrosis compensada tratados en el estudio CREST.
Gastroenterol Hepatol
; 47(6): 605-611, 2024.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38355095
4.
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction. / Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica.
Gastroenterol Hepatol
; 46(2): 150-162, 2023 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36257502
5.
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
Liver Int
; 41(9): 2076-2086, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896100
6.
Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain.
J Gastroenterol Hepatol
; 36(6): 1627-1633, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184937
7.
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
J Hepatol
; 73(1): 17-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147361
8.
Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG.
Rev Esp Enferm Dig
; 112(5): 397-411, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316737
9.
Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG. / Restablecimiento de la actividad en los servicios de Digestivo. Recomendaciones de la SEPD, AEEH, GETECCU y AEG.
Gastroenterol Hepatol
; 43(6): 332-347, 2020.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32409107
10.
Optimisation in the multidisciplinary approach to patients with hepatitis C in the era of direct-acting antivirals. / Optimización en el abordaje multidisciplinar del paciente con hepatitis C en la era de los antivirales de acción directa.
Gastroenterol Hepatol
; 42 Suppl 1: 8-13, 2019 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32560771
11.
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. / Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH.
Gastroenterol Hepatol
; 42(10): 657-676, 2019 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31771785
12.
A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination.
Liver Int
; 43(5): 1145-1147, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700337
13.
New coeliac disease treatments and their complications. / Nuevas terapias en la enfermedad celiaca y sus complicaciones.
Gastroenterol Hepatol
; 41(3): 191-204, 2018 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-29422237
14.
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. / Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica.
Gastroenterol Hepatol
; 41(5): 328-349, 2018 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-29631866
15.
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
J Hepatol
; 66(6): 1138-1148, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189751
16.
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection.
Clin Gastroenterol Hepatol
; 15(6): 945-949.e1, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28238958
17.
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Gut
; 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876479
18.
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).
J Hepatol
; 73(3): 740-741, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654856
19.
Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.
Liver Int
; 35(2): 401-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24650000
20.
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.
Ann Hepatol
; 14(4): 477-86, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26019034